염증성 장질환 : 세계 임상시험 개요(2026년)

GlobalData's clinical trial report, "Inflammatory Bowel Disease - Global Clinical Trials Review, 2026" provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

• Report Guidance
• GlobalData Clinical Trials Report Coverage
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa
• Top Five Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by G7 Countries: Proportion of Inflammatory Bowel Disease to Gastrointestinal Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries: Proportion of Inflammatory Bowel Disease to Gastrointestinal Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Subjects Recruited Over a Period of Time
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Inflammatory Bowel Disease Therapeutics Clinical Trials
• Prominent Drugs
• Latest Clinical Trials News on Inflammatory Bowel Disease
• Jul 08, 2026: Seres Therapeutics Announces Early Clinical Data of SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis (irEC)
• Jun 10, 2026: Calibr-Skaggs Advances CLF065, a Regenerative GLP-2 Therapy, Into Two Phase 2 IBD Studies
• Jun 08, 2026: Shattuck Labs Announces Preclinical Data of SL-846
• Jun 05, 2026: Shattuck Labs to Host Investor Call and Webcast on Phase 1 Clinical Data of SL-325, a DR3 Blocking Antibody, and Pipeline Update on June 8
• Jun 04, 2026: Mabwell's 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease
• May 27, 2026: Eom Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients
• May 08, 2026: World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application
• May 05, 2026: Epirium Bio Presenting New Preclinical Data on its 15-PGDH Inhibitor Program in Inflammatory Bowel Disease at Digestive Disease Week 2026
• May 05, 2026: Epirium Bio Presenting New Preclinical Data on MF-1305 at Digestive Disease Week 2026
• May 05, 2026: Kymera Therapeutics Presents New Preclinical IBD Data for KT-579, a First-In-Class, Oral IRF5 Degrader, at Digestive Disease Week
• May 05, 2026: Johnson & Johnson Investigational Co-Antibody Therapy JNJ-4804 Shows Potential to Raise the Bar for Clinical Efficacy in Treating Refractory IBD
• May 04, 2026: Seres Therapeutics Presents Preclinical Data at DDW 2026 Supporting SER-603, a Next-Generation Cultivated Live Biotherapeutic Candidate, for IBD
• May 04, 2026: Xencor To Host Webcast To Discuss XmAb942 Data Presentations at DDW
• May 04, 2026: Xencor To Host Webcast To Discuss XmAb412 Data Presentations at DDW
• Clinical Trial Profile Snapshots

Appendix

• Abbreviations
• Definitions
• Research Methodology
• Secondary Research
• About GlobalData
• Contact Us
• Source